explore -WSS

explore

author：focus 2025-09-27 12:57:29 - browse：4

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： ProMED sees offers of support, but its future remains unclear

explore

WSS

What the Wegovy shortage looks like for doctors — and for patients

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Beware the threat of staffing cuts at the CDC

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

A fraught question for the kids of Alzheimer’s: Is it coming for us?

New details revealed about Purdue's marketing of OxyContin

focus

explore

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Supreme Court strikes down use of affirmative action

Wellcome Trust names Røttingen as its new CEO

Apple is now the first public company to be valued at $3 trillion

Massive project maps cells in human brain in unprecedented detail

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A fraught question for the kids of Alzheimer’s: Is it coming for us?

As demand for Covid shots wanes, Moderna seeks its next success

Evacuations in place as 3 wildfires burn in eastern Washington state

entertainment

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Wellcome Trust names Røttingen as its new CEO

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

How doctors and nurses shape Google's AI

STAT Readout Newsletter: Today in biotech, life science news

Baltimore teen accused of firing into crowd during block party mass shooting

explore

focus

hotspot

hotspot